Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Kidney Transplantation | 107 | 2024 | 4236 | 7.460 |
Why?
|
Transplantation Tolerance | 38 | 2023 | 605 | 7.380 |
Why?
|
Transplantation Chimera | 40 | 2022 | 594 | 6.720 |
Why?
|
Bone Marrow Transplantation | 42 | 2022 | 2693 | 4.690 |
Why?
|
Graft Survival | 50 | 2024 | 3818 | 3.570 |
Why?
|
Chimerism | 12 | 2023 | 155 | 3.490 |
Why?
|
Transplantation Conditioning | 25 | 2022 | 1590 | 3.030 |
Why?
|
Graft Rejection | 51 | 2024 | 4446 | 2.820 |
Why?
|
Immune Tolerance | 32 | 2023 | 2300 | 2.760 |
Why?
|
Macaca fascicularis | 48 | 2023 | 903 | 2.570 |
Why?
|
Immunosuppressive Agents | 32 | 2024 | 4173 | 1.480 |
Why?
|
HLA Antigens | 11 | 2019 | 1371 | 1.410 |
Why?
|
Kidney Failure, Chronic | 20 | 2024 | 2471 | 1.350 |
Why?
|
Transplantation, Homologous | 38 | 2022 | 4810 | 1.240 |
Why?
|
Organ Transplantation | 10 | 2022 | 1157 | 1.180 |
Why?
|
Histocompatibility Testing | 18 | 2020 | 719 | 1.100 |
Why?
|
Islets of Langerhans Transplantation | 4 | 2019 | 740 | 1.040 |
Why?
|
Hematopoietic Stem Cell Transplantation | 9 | 2023 | 5670 | 0.960 |
Why?
|
Living Donors | 8 | 2021 | 641 | 0.960 |
Why?
|
Isoantibodies | 12 | 2020 | 674 | 0.910 |
Why?
|
Primates | 9 | 2023 | 524 | 0.880 |
Why?
|
Immunologic Memory | 8 | 2017 | 1359 | 0.820 |
Why?
|
Kidney | 19 | 2024 | 7049 | 0.810 |
Why?
|
Histocompatibility | 4 | 2018 | 317 | 0.780 |
Why?
|
Liver Transplantation | 17 | 2023 | 2333 | 0.770 |
Why?
|
Transplantation, Heterologous | 14 | 2024 | 2385 | 0.760 |
Why?
|
Antibodies, Monoclonal | 15 | 2023 | 9180 | 0.620 |
Why?
|
Tissue Donors | 13 | 2023 | 2331 | 0.610 |
Why?
|
Nephrectomy | 4 | 2012 | 936 | 0.600 |
Why?
|
CD40 Ligand | 6 | 2023 | 526 | 0.590 |
Why?
|
Major Histocompatibility Complex | 10 | 2020 | 927 | 0.590 |
Why?
|
Interleukin-2 | 3 | 2015 | 1891 | 0.570 |
Why?
|
T-Lymphocytes, Regulatory | 7 | 2019 | 3075 | 0.540 |
Why?
|
Animals | 92 | 2024 | 168388 | 0.530 |
Why?
|
Transplantation Immunology | 4 | 2015 | 532 | 0.530 |
Why?
|
Renal Dialysis | 9 | 2022 | 1801 | 0.510 |
Why?
|
Hypertension | 6 | 2016 | 8539 | 0.480 |
Why?
|
Hand-Assisted Laparoscopy | 1 | 2012 | 15 | 0.420 |
Why?
|
T-Lymphocytes | 15 | 2015 | 10191 | 0.410 |
Why?
|
Organ Preservation | 7 | 2024 | 382 | 0.400 |
Why?
|
Models, Animal | 8 | 2019 | 2112 | 0.400 |
Why?
|
Hematopoiesis | 2 | 2019 | 2049 | 0.400 |
Why?
|
Ultrasonography, Doppler | 2 | 2011 | 461 | 0.400 |
Why?
|
Adaptation, Physiological | 2 | 2010 | 1301 | 0.390 |
Why?
|
Graft Occlusion, Vascular | 3 | 2022 | 537 | 0.390 |
Why?
|
Immunotoxins | 1 | 2012 | 175 | 0.390 |
Why?
|
Diphtheria Toxin | 1 | 2012 | 252 | 0.380 |
Why?
|
Polytetrafluoroethylene | 2 | 2011 | 246 | 0.370 |
Why?
|
Vascular Resistance | 2 | 2011 | 932 | 0.370 |
Why?
|
Arteriovenous Shunt, Surgical | 3 | 2022 | 292 | 0.370 |
Why?
|
CD8-Positive T-Lymphocytes | 5 | 2018 | 4576 | 0.370 |
Why?
|
Stem Cell Transplantation | 1 | 2018 | 1598 | 0.340 |
Why?
|
Stem Cell Factor | 1 | 2010 | 195 | 0.340 |
Why?
|
Swine | 10 | 2024 | 5915 | 0.330 |
Why?
|
Antilymphocyte Serum | 8 | 2015 | 487 | 0.320 |
Why?
|
Hematopoietic Stem Cell Mobilization | 1 | 2010 | 225 | 0.320 |
Why?
|
Carotid Arteries | 1 | 2013 | 941 | 0.320 |
Why?
|
Brain Death | 5 | 2023 | 357 | 0.320 |
Why?
|
Multiple Myeloma | 4 | 2019 | 5146 | 0.310 |
Why?
|
Lymphocele | 1 | 2008 | 18 | 0.310 |
Why?
|
Recombinant Fusion Proteins | 4 | 2013 | 3734 | 0.310 |
Why?
|
Killer Cells, Natural | 2 | 2012 | 2203 | 0.300 |
Why?
|
Kidney Diseases | 4 | 2014 | 2093 | 0.300 |
Why?
|
Blood Vessel Prosthesis | 3 | 2011 | 954 | 0.300 |
Why?
|
Islets of Langerhans | 5 | 2003 | 1346 | 0.300 |
Why?
|
Histocompatibility Antigens | 2 | 2020 | 467 | 0.290 |
Why?
|
Granulocyte Colony-Stimulating Factor | 1 | 2010 | 629 | 0.280 |
Why?
|
Splenectomy | 8 | 2010 | 391 | 0.270 |
Why?
|
RNA, Messenger | 3 | 2019 | 12787 | 0.270 |
Why?
|
Uric Acid | 1 | 2012 | 808 | 0.260 |
Why?
|
Whole-Body Irradiation | 9 | 2009 | 433 | 0.260 |
Why?
|
Carotid Stenosis | 1 | 2013 | 860 | 0.260 |
Why?
|
Cyclosporine | 8 | 2015 | 778 | 0.250 |
Why?
|
Humans | 107 | 2024 | 761326 | 0.250 |
Why?
|
Renal Insufficiency | 1 | 2011 | 809 | 0.240 |
Why?
|
Graft vs Host Disease | 2 | 2017 | 3030 | 0.240 |
Why?
|
Tissue and Organ Harvesting | 1 | 2008 | 373 | 0.240 |
Why?
|
Male | 78 | 2024 | 360621 | 0.230 |
Why?
|
Vascular Patency | 5 | 2022 | 910 | 0.230 |
Why?
|
Follow-Up Studies | 16 | 2020 | 39108 | 0.230 |
Why?
|
Papio | 4 | 2024 | 669 | 0.230 |
Why?
|
Lymphatic Vessels | 1 | 2008 | 358 | 0.220 |
Why?
|
Liver Failure, Acute | 2 | 2018 | 181 | 0.220 |
Why?
|
Brachial Artery | 2 | 2017 | 366 | 0.220 |
Why?
|
Transplantation | 2 | 1995 | 219 | 0.220 |
Why?
|
Lymphocyte Depletion | 8 | 2010 | 602 | 0.210 |
Why?
|
Animals, Genetically Modified | 3 | 2024 | 1561 | 0.210 |
Why?
|
Neutropenia | 1 | 2008 | 884 | 0.210 |
Why?
|
Time Factors | 21 | 2019 | 39974 | 0.210 |
Why?
|
Genes, bcl-2 | 1 | 2023 | 119 | 0.210 |
Why?
|
Perfusion | 5 | 2024 | 1374 | 0.210 |
Why?
|
Hematopoietic Stem Cells | 2 | 2015 | 3396 | 0.210 |
Why?
|
Galactosyltransferases | 1 | 2024 | 276 | 0.210 |
Why?
|
Radiographic Image Enhancement | 1 | 2007 | 876 | 0.210 |
Why?
|
Cyclophosphamide | 1 | 2008 | 2218 | 0.210 |
Why?
|
Kaplan-Meier Estimate | 7 | 2017 | 6473 | 0.210 |
Why?
|
Cell Separation | 3 | 2003 | 1722 | 0.200 |
Why?
|
Tissue and Organ Procurement | 5 | 2021 | 961 | 0.200 |
Why?
|
Carcinoma, Hepatocellular | 3 | 2023 | 2299 | 0.200 |
Why?
|
Clinical Protocols | 2 | 2020 | 1440 | 0.190 |
Why?
|
Kidney Function Tests | 4 | 2015 | 678 | 0.190 |
Why?
|
CD4-Positive T-Lymphocytes | 4 | 2014 | 4371 | 0.190 |
Why?
|
Postoperative Complications | 13 | 2019 | 15647 | 0.190 |
Why?
|
Skin Transplantation | 3 | 2020 | 1083 | 0.180 |
Why?
|
Renin | 1 | 2023 | 639 | 0.180 |
Why?
|
User-Computer Interface | 1 | 2007 | 1399 | 0.180 |
Why?
|
Clinical Trials as Topic | 4 | 2022 | 7999 | 0.180 |
Why?
|
Glomerular Filtration Rate | 4 | 2015 | 2176 | 0.180 |
Why?
|
Cyclosporins | 9 | 1990 | 216 | 0.180 |
Why?
|
End Stage Liver Disease | 2 | 2023 | 352 | 0.170 |
Why?
|
Expert Testimony | 1 | 2022 | 363 | 0.170 |
Why?
|
Immunologic Techniques | 1 | 1999 | 213 | 0.170 |
Why?
|
Lung Transplantation | 3 | 2015 | 1309 | 0.170 |
Why?
|
GATA3 Transcription Factor | 1 | 2019 | 152 | 0.160 |
Why?
|
Blood Pressure | 2 | 2011 | 8485 | 0.160 |
Why?
|
Japan | 5 | 2016 | 1372 | 0.160 |
Why?
|
Stroke | 4 | 2014 | 9749 | 0.160 |
Why?
|
Retrospective Studies | 24 | 2023 | 80575 | 0.160 |
Why?
|
Liver Neoplasms | 3 | 2023 | 4321 | 0.160 |
Why?
|
Atherosclerosis | 2 | 2013 | 3413 | 0.160 |
Why?
|
Middle Aged | 37 | 2023 | 220774 | 0.160 |
Why?
|
Heat Stroke | 1 | 2018 | 29 | 0.160 |
Why?
|
Diabetes Mellitus, Experimental | 2 | 2003 | 1115 | 0.160 |
Why?
|
Renal Circulation | 3 | 2011 | 291 | 0.150 |
Why?
|
Female | 53 | 2024 | 392485 | 0.150 |
Why?
|
Thromboembolism | 2 | 2004 | 996 | 0.150 |
Why?
|
ABO Blood-Group System | 5 | 2009 | 380 | 0.140 |
Why?
|
Isoantigens | 3 | 2015 | 552 | 0.140 |
Why?
|
Forkhead Transcription Factors | 2 | 2019 | 1612 | 0.140 |
Why?
|
Graft vs Host Reaction | 1 | 1997 | 103 | 0.140 |
Why?
|
B-Lymphocytes | 4 | 2017 | 4764 | 0.140 |
Why?
|
Pancreas Transplantation | 3 | 1995 | 197 | 0.140 |
Why?
|
Cardiovascular Diseases | 2 | 2012 | 15499 | 0.140 |
Why?
|
Liver | 8 | 2022 | 7531 | 0.130 |
Why?
|
Flow Cytometry | 8 | 2012 | 5866 | 0.130 |
Why?
|
Haplorhini | 3 | 2009 | 529 | 0.130 |
Why?
|
Liver Failure | 1 | 2018 | 250 | 0.130 |
Why?
|
Immunoglobulin G | 5 | 2023 | 4550 | 0.130 |
Why?
|
Treatment Outcome | 18 | 2022 | 64645 | 0.130 |
Why?
|
Delayed Graft Function | 2 | 2012 | 53 | 0.130 |
Why?
|
Research Report | 1 | 2018 | 367 | 0.120 |
Why?
|
Radial Artery | 1 | 2017 | 186 | 0.120 |
Why?
|
Vascular Diseases | 2 | 2022 | 1161 | 0.120 |
Why?
|
Clonal Deletion | 1 | 2015 | 74 | 0.120 |
Why?
|
Mice | 12 | 2024 | 81474 | 0.120 |
Why?
|
Bone Marrow | 4 | 2020 | 2909 | 0.120 |
Why?
|
Superior Vena Cava Syndrome | 1 | 2015 | 56 | 0.120 |
Why?
|
Heart Transplantation | 4 | 2002 | 3234 | 0.120 |
Why?
|
Death | 2 | 2010 | 676 | 0.120 |
Why?
|
Thymus Gland | 4 | 2007 | 1241 | 0.120 |
Why?
|
Lymphocyte Transfusion | 1 | 2015 | 232 | 0.120 |
Why?
|
Creatinine | 6 | 2012 | 1899 | 0.110 |
Why?
|
Interleukin-10 | 1 | 2019 | 1175 | 0.110 |
Why?
|
Adult | 37 | 2023 | 221122 | 0.110 |
Why?
|
Risk Factors | 11 | 2023 | 74152 | 0.110 |
Why?
|
Hyperoxaluria, Primary | 1 | 2013 | 24 | 0.110 |
Why?
|
Ankle Brachial Index | 1 | 2014 | 163 | 0.110 |
Why?
|
Angioplasty, Balloon | 1 | 2017 | 588 | 0.110 |
Why?
|
Th1 Cells | 1 | 2018 | 1037 | 0.110 |
Why?
|
Ureterostomy | 1 | 2012 | 18 | 0.100 |
Why?
|
Chromosomes, Human, Pair 9 | 1 | 2014 | 535 | 0.100 |
Why?
|
Predictive Value of Tests | 3 | 2014 | 15262 | 0.100 |
Why?
|
Veins | 1 | 2017 | 768 | 0.100 |
Why?
|
Catheters, Indwelling | 1 | 2015 | 427 | 0.100 |
Why?
|
Peripheral Blood Stem Cell Transplantation | 2 | 2014 | 263 | 0.100 |
Why?
|
Cystostomy | 1 | 2012 | 25 | 0.100 |
Why?
|
Hepatitis C | 3 | 2020 | 1584 | 0.100 |
Why?
|
Protein S Deficiency | 1 | 2011 | 13 | 0.100 |
Why?
|
Hypertension, Malignant | 1 | 2012 | 17 | 0.100 |
Why?
|
Genotype | 2 | 2019 | 12982 | 0.100 |
Why?
|
Survival Rate | 6 | 2013 | 12710 | 0.100 |
Why?
|
Membrane Glycoproteins | 2 | 2000 | 3701 | 0.100 |
Why?
|
Myeloablative Agonists | 1 | 2013 | 209 | 0.100 |
Why?
|
Mannose | 5 | 1990 | 121 | 0.100 |
Why?
|
Muromonab-CD3 | 2 | 1996 | 104 | 0.100 |
Why?
|
Upper Extremity | 1 | 2017 | 657 | 0.100 |
Why?
|
Immunoconjugates | 1 | 1999 | 954 | 0.100 |
Why?
|
Transforming Growth Factor beta | 1 | 2019 | 1959 | 0.100 |
Why?
|
Hepatitis C, Chronic | 1 | 2020 | 1032 | 0.100 |
Why?
|
Capillary Leak Syndrome | 1 | 2011 | 34 | 0.100 |
Why?
|
Interleukin-15 | 1 | 2012 | 185 | 0.090 |
Why?
|
Prognosis | 5 | 2020 | 29588 | 0.090 |
Why?
|
Aged | 16 | 2019 | 169179 | 0.090 |
Why?
|
Learning Curve | 1 | 2012 | 230 | 0.090 |
Why?
|
Cattle | 2 | 2015 | 3849 | 0.090 |
Why?
|
Portal Vein | 1 | 2013 | 431 | 0.090 |
Why?
|
Drug Therapy, Combination | 2 | 2018 | 6309 | 0.090 |
Why?
|
Leukocyte Count | 4 | 2011 | 1597 | 0.090 |
Why?
|
C-Peptide | 2 | 2003 | 440 | 0.090 |
Why?
|
Organ Specificity | 1 | 2015 | 1967 | 0.090 |
Why?
|
4-Aminobenzoic Acid | 5 | 1990 | 22 | 0.090 |
Why?
|
Leukapheresis | 1 | 2010 | 134 | 0.090 |
Why?
|
Prospective Studies | 5 | 2023 | 54405 | 0.080 |
Why?
|
Ureter | 1 | 2012 | 367 | 0.080 |
Why?
|
Ankle | 1 | 2012 | 350 | 0.080 |
Why?
|
Receptors, Antigen, T-Cell | 2 | 2017 | 2549 | 0.080 |
Why?
|
Blood Substitutes | 4 | 1992 | 57 | 0.080 |
Why?
|
Blood Pressure Monitoring, Ambulatory | 1 | 2011 | 244 | 0.080 |
Why?
|
Antineoplastic Agents | 1 | 2012 | 13635 | 0.080 |
Why?
|
Blood Pressure Determination | 1 | 2012 | 634 | 0.080 |
Why?
|
History, 21st Century | 1 | 2015 | 1567 | 0.080 |
Why?
|
Cadaver | 2 | 2008 | 1358 | 0.080 |
Why?
|
Proteinuria | 1 | 2011 | 607 | 0.080 |
Why?
|
Blood Loss, Surgical | 1 | 2012 | 636 | 0.080 |
Why?
|
Models, Theoretical | 1 | 2020 | 3577 | 0.080 |
Why?
|
Lymphatic Irradiation | 1 | 2008 | 115 | 0.080 |
Why?
|
Biopsy | 4 | 2008 | 6768 | 0.080 |
Why?
|
Disease-Free Survival | 2 | 2020 | 6815 | 0.080 |
Why?
|
Blood Flow Velocity | 1 | 2011 | 1370 | 0.070 |
Why?
|
Hepatocyte Nuclear Factor 3-alpha | 1 | 2008 | 164 | 0.070 |
Why?
|
Hematologic Neoplasms | 1 | 2019 | 1896 | 0.070 |
Why?
|
Blood Coagulation Disorders | 2 | 2000 | 350 | 0.070 |
Why?
|
Arteriosclerosis | 1 | 2011 | 1055 | 0.070 |
Why?
|
History, 20th Century | 1 | 2015 | 2770 | 0.070 |
Why?
|
Disease Models, Animal | 3 | 2017 | 18234 | 0.070 |
Why?
|
Longevity | 1 | 2014 | 1065 | 0.070 |
Why?
|
Granzymes | 1 | 2008 | 277 | 0.070 |
Why?
|
Blood Group Incompatibility | 2 | 1998 | 136 | 0.070 |
Why?
|
Cytomegalovirus Infections | 3 | 2017 | 831 | 0.070 |
Why?
|
Thrombolytic Therapy | 1 | 2015 | 2062 | 0.070 |
Why?
|
Bone Marrow Cells | 1 | 2013 | 2416 | 0.060 |
Why?
|
Blood Transfusion | 1 | 2012 | 1299 | 0.060 |
Why?
|
Biocompatible Materials | 2 | 2011 | 1689 | 0.060 |
Why?
|
Nephritis, Hereditary | 1 | 2006 | 78 | 0.060 |
Why?
|
Blood Vessel Prosthesis Implantation | 1 | 2016 | 1427 | 0.060 |
Why?
|
Cohort Studies | 3 | 2013 | 41440 | 0.060 |
Why?
|
Fibrinolytic Agents | 1 | 2015 | 2082 | 0.060 |
Why?
|
Postoperative Care | 1 | 1992 | 1471 | 0.060 |
Why?
|
Plasmacytoma | 1 | 2006 | 171 | 0.060 |
Why?
|
Interferon-gamma | 1 | 2013 | 3159 | 0.060 |
Why?
|
Lymphocyte Culture Test, Mixed | 4 | 2015 | 516 | 0.060 |
Why?
|
ROC Curve | 1 | 2012 | 3572 | 0.060 |
Why?
|
Cell Proliferation | 2 | 2017 | 10431 | 0.060 |
Why?
|
Tissue Preservation | 3 | 1992 | 174 | 0.060 |
Why?
|
Lung Diseases | 1 | 2015 | 1909 | 0.060 |
Why?
|
Haplotypes | 1 | 2011 | 2774 | 0.060 |
Why?
|
Adoptive Transfer | 1 | 2007 | 819 | 0.060 |
Why?
|
Acute Kidney Injury | 2 | 2020 | 1926 | 0.060 |
Why?
|
Swine, Miniature | 2 | 2023 | 961 | 0.060 |
Why?
|
Tomography, X-Ray Computed | 1 | 2007 | 20555 | 0.060 |
Why?
|
Blood Vessels | 2 | 1999 | 1113 | 0.060 |
Why?
|
Age Factors | 3 | 2016 | 18401 | 0.060 |
Why?
|
Foundations | 1 | 2024 | 95 | 0.060 |
Why?
|
Aging | 2 | 2016 | 8704 | 0.060 |
Why?
|
Embolization, Therapeutic | 1 | 2013 | 1418 | 0.050 |
Why?
|
Hepatic Encephalopathy | 2 | 2012 | 144 | 0.050 |
Why?
|
Receptors, Tumor Necrosis Factor | 1 | 1996 | 584 | 0.050 |
Why?
|
Asia | 2 | 1995 | 618 | 0.050 |
Why?
|
Proportional Hazards Models | 2 | 2017 | 12450 | 0.050 |
Why?
|
Disaccharides | 1 | 2003 | 170 | 0.050 |
Why?
|
Serum Albumin, Bovine | 1 | 2003 | 322 | 0.050 |
Why?
|
Analysis of Variance | 1 | 2011 | 6231 | 0.050 |
Why?
|
Chimera | 3 | 1999 | 453 | 0.050 |
Why?
|
Radiology Information Systems | 1 | 2007 | 529 | 0.050 |
Why?
|
Preoperative Care | 1 | 1992 | 2242 | 0.050 |
Why?
|
Drainage | 1 | 2008 | 1156 | 0.050 |
Why?
|
Evidence-Based Medicine | 1 | 2014 | 3687 | 0.050 |
Why?
|
Antihypertensive Agents | 1 | 2011 | 2023 | 0.050 |
Why?
|
Sex Characteristics | 1 | 2012 | 2637 | 0.050 |
Why?
|
Registries | 2 | 2014 | 8223 | 0.050 |
Why?
|
Intestine, Small | 3 | 1992 | 1205 | 0.050 |
Why?
|
Gene Knockout Techniques | 1 | 2024 | 802 | 0.050 |
Why?
|
Thrombophilia | 1 | 2004 | 305 | 0.050 |
Why?
|
Combined Modality Therapy | 3 | 2013 | 8526 | 0.050 |
Why?
|
Lymph Nodes | 3 | 2009 | 3469 | 0.050 |
Why?
|
Cytokines | 1 | 2015 | 7390 | 0.040 |
Why?
|
Radiographic Image Interpretation, Computer-Assisted | 1 | 2007 | 1222 | 0.040 |
Why?
|
Patient Selection | 3 | 2022 | 4244 | 0.040 |
Why?
|
Decision Support Techniques | 1 | 2010 | 1998 | 0.040 |
Why?
|
Transgenes | 1 | 2023 | 1009 | 0.040 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2012 | 10764 | 0.040 |
Why?
|
Plasmapheresis | 2 | 1998 | 206 | 0.040 |
Why?
|
Mice, Inbred CBA | 1 | 2020 | 436 | 0.040 |
Why?
|
Thrombosis | 3 | 2000 | 2942 | 0.040 |
Why?
|
Laparoscopy | 2 | 2009 | 2035 | 0.040 |
Why?
|
Boston | 3 | 2017 | 9333 | 0.040 |
Why?
|
Prostaglandins | 3 | 1989 | 398 | 0.040 |
Why?
|
Hepatectomy | 2 | 2020 | 558 | 0.040 |
Why?
|
Waiting Lists | 1 | 2024 | 765 | 0.040 |
Why?
|
Pennsylvania | 1 | 2020 | 613 | 0.040 |
Why?
|
Cryopreservation | 1 | 2024 | 728 | 0.040 |
Why?
|
Alprostadil | 2 | 2004 | 86 | 0.040 |
Why?
|
Hemoglobins | 3 | 1992 | 1524 | 0.040 |
Why?
|
Horses | 2 | 2015 | 300 | 0.040 |
Why?
|
Disease Progression | 2 | 2014 | 13500 | 0.040 |
Why?
|
Constriction, Pathologic | 1 | 2022 | 1097 | 0.040 |
Why?
|
Mice, Inbred BALB C | 2 | 2020 | 6210 | 0.040 |
Why?
|
Cost of Illness | 1 | 2008 | 1935 | 0.040 |
Why?
|
Lymphoproliferative Disorders | 1 | 2002 | 533 | 0.040 |
Why?
|
Cognition | 1 | 2016 | 6987 | 0.040 |
Why?
|
Child | 11 | 2022 | 80156 | 0.040 |
Why?
|
Stents | 2 | 2022 | 3179 | 0.040 |
Why?
|
Congresses as Topic | 1 | 2023 | 803 | 0.040 |
Why?
|
Genes, Immunoglobulin Heavy Chain | 1 | 2017 | 57 | 0.040 |
Why?
|
Antibodies | 2 | 2022 | 2421 | 0.040 |
Why?
|
Antibody Formation | 3 | 1997 | 1397 | 0.040 |
Why?
|
Blood Glucose | 2 | 2003 | 6389 | 0.040 |
Why?
|
Incidence | 2 | 2014 | 21336 | 0.040 |
Why?
|
Spleen | 1 | 2003 | 2296 | 0.040 |
Why?
|
Polysaccharides | 1 | 2023 | 1014 | 0.030 |
Why?
|
Diabetes Mellitus | 2 | 2011 | 5841 | 0.030 |
Why?
|
Clinical Competence | 1 | 2012 | 4793 | 0.030 |
Why?
|
Dogs | 6 | 1992 | 3839 | 0.030 |
Why?
|
Platelet Activation | 1 | 2000 | 645 | 0.030 |
Why?
|
Medication Adherence | 1 | 2008 | 2176 | 0.030 |
Why?
|
Antigens, Differentiation | 1 | 1999 | 910 | 0.030 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2011 | 3244 | 0.030 |
Why?
|
Neoplasm Recurrence, Local | 3 | 2023 | 9275 | 0.030 |
Why?
|
Mice, Nude | 1 | 2003 | 3603 | 0.030 |
Why?
|
Lymphocyte Activation | 2 | 1999 | 5491 | 0.030 |
Why?
|
Prevalence | 1 | 2013 | 15719 | 0.030 |
Why?
|
Antiviral Agents | 2 | 2020 | 3057 | 0.030 |
Why?
|
Longitudinal Studies | 1 | 2012 | 14597 | 0.030 |
Why?
|
Epstein-Barr Virus Infections | 1 | 2002 | 612 | 0.030 |
Why?
|
Neutrophils | 1 | 2008 | 3765 | 0.030 |
Why?
|
Cells, Cultured | 4 | 2017 | 18962 | 0.030 |
Why?
|
Antigens, Viral | 2 | 1997 | 987 | 0.030 |
Why?
|
Lymphocyte Count | 1 | 2017 | 778 | 0.030 |
Why?
|
Adolescent | 14 | 2014 | 88305 | 0.030 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2014 | 15879 | 0.030 |
Why?
|
Coronary Artery Disease | 1 | 2014 | 6392 | 0.030 |
Why?
|
Survival Analysis | 2 | 1999 | 10075 | 0.030 |
Why?
|
Polyethylene Glycols | 2 | 1992 | 1188 | 0.030 |
Why?
|
Complementarity Determining Regions | 1 | 2015 | 149 | 0.030 |
Why?
|
Blood Coagulation | 1 | 2000 | 1154 | 0.030 |
Why?
|
Health Care Costs | 1 | 2007 | 3243 | 0.030 |
Why?
|
Chronic Disease | 5 | 2011 | 9319 | 0.030 |
Why?
|
Thromboxane B2 | 2 | 1991 | 143 | 0.030 |
Why?
|
Antigens, CD | 2 | 2007 | 4000 | 0.030 |
Why?
|
Pilot Projects | 2 | 2019 | 8632 | 0.030 |
Why?
|
Family | 2 | 1995 | 3197 | 0.030 |
Why?
|
Phlebography | 1 | 2015 | 326 | 0.030 |
Why?
|
Injections, Subcutaneous | 1 | 2015 | 680 | 0.030 |
Why?
|
Comorbidity | 2 | 2021 | 10498 | 0.030 |
Why?
|
Antigens, CD20 | 1 | 2014 | 201 | 0.030 |
Why?
|
Mutation | 2 | 2017 | 30044 | 0.030 |
Why?
|
Glomerulosclerosis, Focal Segmental | 1 | 1997 | 335 | 0.030 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 3 | 2009 | 3806 | 0.030 |
Why?
|
Receptors, Interleukin-6 | 1 | 2015 | 225 | 0.030 |
Why?
|
Young Adult | 3 | 2014 | 59196 | 0.030 |
Why?
|
Hospitals, General | 1 | 2017 | 798 | 0.030 |
Why?
|
Oxalates | 1 | 2013 | 98 | 0.030 |
Why?
|
Polymerase Chain Reaction | 3 | 1997 | 6086 | 0.030 |
Why?
|
Hepacivirus | 1 | 2020 | 1337 | 0.030 |
Why?
|
Tacrolimus | 1 | 1996 | 733 | 0.030 |
Why?
|
Protein S | 1 | 2011 | 30 | 0.030 |
Why?
|
Epoprostenol | 3 | 1988 | 246 | 0.030 |
Why?
|
Sensitivity and Specificity | 1 | 2007 | 14665 | 0.020 |
Why?
|
Interferon-alpha | 1 | 1996 | 921 | 0.020 |
Why?
|
Radiation Chimera | 1 | 2011 | 216 | 0.020 |
Why?
|
Kidney Tubular Necrosis, Acute | 1 | 2011 | 65 | 0.020 |
Why?
|
Organ Preservation Solutions | 1 | 1992 | 100 | 0.020 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2014 | 696 | 0.020 |
Why?
|
6-Ketoprostaglandin F1 alpha | 1 | 1991 | 80 | 0.020 |
Why?
|
Rats, Inbred Lew | 4 | 1996 | 1158 | 0.020 |
Why?
|
Rats, Inbred Strains | 5 | 1990 | 2090 | 0.020 |
Why?
|
Hemostasis, Surgical | 1 | 2011 | 126 | 0.020 |
Why?
|
Endothelial Cells | 1 | 2023 | 3543 | 0.020 |
Why?
|
Rupture, Spontaneous | 1 | 2011 | 362 | 0.020 |
Why?
|
Thrombophlebitis | 1 | 1991 | 289 | 0.020 |
Why?
|
Device Removal | 1 | 2015 | 630 | 0.020 |
Why?
|
Transplantation, Autologous | 1 | 2015 | 2115 | 0.020 |
Why?
|
Insulin | 3 | 2001 | 6595 | 0.020 |
Why?
|
Parathyroidectomy | 1 | 1992 | 242 | 0.020 |
Why?
|
Lymphatic System | 1 | 1991 | 254 | 0.020 |
Why?
|
Chi-Square Distribution | 1 | 2016 | 3419 | 0.020 |
Why?
|
Intracranial Pressure | 1 | 2012 | 324 | 0.020 |
Why?
|
Linkage Disequilibrium | 1 | 2014 | 2004 | 0.020 |
Why?
|
Intracranial Hypertension | 1 | 2012 | 193 | 0.020 |
Why?
|
Immunohistochemistry | 3 | 2011 | 11070 | 0.020 |
Why?
|
Polyurethanes | 1 | 1989 | 108 | 0.020 |
Why?
|
Complement C4b | 1 | 2009 | 132 | 0.020 |
Why?
|
Life Expectancy | 1 | 2016 | 1242 | 0.020 |
Why?
|
Hepatitis Viruses | 1 | 1988 | 15 | 0.020 |
Why?
|
Walking | 1 | 2016 | 1200 | 0.020 |
Why?
|
Purpura, Thrombocytopenic | 1 | 1988 | 41 | 0.020 |
Why?
|
Diabetes Mellitus, Type 2 | 2 | 2011 | 12144 | 0.020 |
Why?
|
International Cooperation | 1 | 1995 | 1428 | 0.020 |
Why?
|
Carpal Tunnel Syndrome | 1 | 1992 | 303 | 0.020 |
Why?
|
Genetic Markers | 1 | 2014 | 2612 | 0.020 |
Why?
|
Europe | 1 | 1995 | 3420 | 0.020 |
Why?
|
Thromboxane-A Synthase | 1 | 1987 | 34 | 0.020 |
Why?
|
Intraoperative Care | 1 | 1992 | 766 | 0.020 |
Why?
|
Macaca mulatta | 1 | 1994 | 2332 | 0.020 |
Why?
|
Protein Array Analysis | 1 | 2009 | 400 | 0.020 |
Why?
|
Platelet Aggregation | 1 | 1991 | 773 | 0.020 |
Why?
|
Coculture Techniques | 1 | 2011 | 1341 | 0.020 |
Why?
|
Acrylates | 1 | 1987 | 79 | 0.020 |
Why?
|
Gabexate | 1 | 1987 | 12 | 0.020 |
Why?
|
Gene Frequency | 1 | 2014 | 3639 | 0.020 |
Why?
|
Postoperative Hemorrhage | 1 | 2011 | 415 | 0.020 |
Why?
|
Pyridoxal Phosphate | 1 | 1987 | 125 | 0.020 |
Why?
|
alpha-Cyclodextrins | 1 | 1987 | 12 | 0.020 |
Why?
|
Methacrylates | 1 | 1987 | 109 | 0.020 |
Why?
|
Recovery of Function | 1 | 2017 | 2977 | 0.020 |
Why?
|
Acute Disease | 3 | 2002 | 7238 | 0.020 |
Why?
|
Rats | 9 | 1996 | 23729 | 0.020 |
Why?
|
Immunophenotyping | 1 | 2011 | 1870 | 0.020 |
Why?
|
Aged, 80 and over | 3 | 2016 | 58946 | 0.020 |
Why?
|
Diagnosis-Related Groups | 1 | 2007 | 449 | 0.020 |
Why?
|
T-Lymphocytes, Cytotoxic | 1 | 1993 | 1783 | 0.020 |
Why?
|
Methylprednisolone | 3 | 1996 | 384 | 0.020 |
Why?
|
Diabetic Nephropathies | 1 | 1992 | 973 | 0.020 |
Why?
|
Monitoring, Intraoperative | 1 | 2012 | 941 | 0.020 |
Why?
|
Resource Allocation | 1 | 2007 | 350 | 0.020 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2011 | 2509 | 0.020 |
Why?
|
Portal System | 2 | 1997 | 49 | 0.020 |
Why?
|
Severity of Illness Index | 1 | 2023 | 15835 | 0.020 |
Why?
|
Antibodies, Viral | 1 | 1996 | 3155 | 0.010 |
Why?
|
Logistic Models | 2 | 2016 | 13251 | 0.010 |
Why?
|
Ketorolac Tromethamine | 1 | 2004 | 21 | 0.010 |
Why?
|
Immune System | 1 | 2009 | 794 | 0.010 |
Why?
|
Phosphates | 1 | 1987 | 770 | 0.010 |
Why?
|
Angiography | 1 | 2009 | 1599 | 0.010 |
Why?
|
Odds Ratio | 1 | 2016 | 9639 | 0.010 |
Why?
|
Dendritic Cells | 1 | 2014 | 2746 | 0.010 |
Why?
|
Gastrointestinal Diseases | 1 | 1992 | 1198 | 0.010 |
Why?
|
Alcohol Drinking | 1 | 2016 | 4027 | 0.010 |
Why?
|
Pregnancy Complications | 1 | 1997 | 2947 | 0.010 |
Why?
|
Signal Transduction | 2 | 2011 | 23427 | 0.010 |
Why?
|
Ticlopidine | 1 | 1987 | 730 | 0.010 |
Why?
|
Guanidines | 2 | 1997 | 192 | 0.010 |
Why?
|
RNA, Nuclear | 1 | 2002 | 30 | 0.010 |
Why?
|
Regeneration | 1 | 1991 | 1511 | 0.010 |
Why?
|
Microscopy, Fluorescence | 1 | 2009 | 2648 | 0.010 |
Why?
|
United States | 2 | 2024 | 72317 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2020 | 22154 | 0.010 |
Why?
|
Diabetes Mellitus, Type 1 | 2 | 1996 | 3441 | 0.010 |
Why?
|
Aspartate Aminotransferases | 2 | 1994 | 416 | 0.010 |
Why?
|
Urinary Tract Infections | 1 | 1988 | 806 | 0.010 |
Why?
|
Reoperation | 1 | 2012 | 4302 | 0.010 |
Why?
|
RNA, Viral | 2 | 2002 | 2846 | 0.010 |
Why?
|
Databases, Factual | 1 | 2016 | 7954 | 0.010 |
Why?
|
Thrombocytopenia | 1 | 1988 | 1179 | 0.010 |
Why?
|
Liver Function Tests | 2 | 1994 | 522 | 0.010 |
Why?
|
Glucose Tolerance Test | 2 | 1996 | 1178 | 0.010 |
Why?
|
Phenotype | 1 | 2017 | 16603 | 0.010 |
Why?
|
Leukocytes, Mononuclear | 1 | 2006 | 1842 | 0.010 |
Why?
|
Syndrome | 1 | 1996 | 3268 | 0.010 |
Why?
|
Genetic Variation | 1 | 2014 | 6571 | 0.010 |
Why?
|
Smoking | 1 | 2016 | 9051 | 0.010 |
Why?
|
Monitoring, Physiologic | 1 | 2006 | 1780 | 0.010 |
Why?
|
Brain Injuries | 1 | 2010 | 2053 | 0.010 |
Why?
|
Immunosorbents | 1 | 1998 | 21 | 0.010 |
Why?
|
In Situ Hybridization | 1 | 2002 | 1900 | 0.010 |
Why?
|
Diet | 1 | 2016 | 8074 | 0.010 |
Why?
|
Immunoglobulin Isotypes | 1 | 1998 | 158 | 0.010 |
Why?
|
Drug Combinations | 1 | 2004 | 2048 | 0.010 |
Why?
|
Dose-Response Relationship, Immunologic | 1 | 1998 | 365 | 0.010 |
Why?
|
Evaluation Studies as Topic | 2 | 1992 | 1626 | 0.010 |
Why?
|
Coronary Disease | 1 | 1992 | 5919 | 0.010 |
Why?
|
Peptide Fragments | 1 | 2009 | 5114 | 0.010 |
Why?
|
Pancytopenia | 1 | 1997 | 102 | 0.010 |
Why?
|
Heparin | 1 | 2004 | 1633 | 0.010 |
Why?
|
Herpesvirus 4, Human | 1 | 2002 | 1079 | 0.010 |
Why?
|
Polymorphism, Single-Stranded Conformational | 1 | 1996 | 330 | 0.010 |
Why?
|
Lung | 1 | 2015 | 9994 | 0.010 |
Why?
|
Recombinant Proteins | 1 | 1996 | 6525 | 0.010 |
Why?
|
Autoimmune Diseases | 1 | 1988 | 2248 | 0.010 |
Why?
|
Antibodies, Anti-Idiotypic | 1 | 1997 | 357 | 0.010 |
Why?
|
Serologic Tests | 1 | 1997 | 384 | 0.010 |
Why?
|
Lupus Erythematosus, Systemic | 1 | 1988 | 2163 | 0.010 |
Why?
|
Transplants | 1 | 1998 | 207 | 0.010 |
Why?
|
Neoplasm Staging | 1 | 2010 | 11098 | 0.010 |
Why?
|
Cell Line | 1 | 2009 | 15599 | 0.010 |
Why?
|
Inflammation | 1 | 2015 | 10760 | 0.010 |
Why?
|
Brain | 1 | 2022 | 27103 | 0.010 |
Why?
|
Pregnancy | 1 | 1997 | 29858 | 0.010 |
Why?
|
Anemia, Aplastic | 1 | 1997 | 230 | 0.010 |
Why?
|
Tissue Distribution | 2 | 1989 | 2265 | 0.010 |
Why?
|
Kidney Glomerulus | 1 | 1997 | 567 | 0.010 |
Why?
|
Fluorescence | 1 | 1997 | 756 | 0.010 |
Why?
|
Likelihood Functions | 1 | 1998 | 991 | 0.010 |
Why?
|
HLA-DR Antigens | 1 | 1996 | 631 | 0.010 |
Why?
|
Cost-Benefit Analysis | 1 | 2007 | 5492 | 0.010 |
Why?
|
Guinea Pigs | 1 | 1996 | 1317 | 0.010 |
Why?
|
Fathers | 1 | 1997 | 376 | 0.010 |
Why?
|
Puerperal Disorders | 1 | 1997 | 299 | 0.010 |
Why?
|
Binding Sites, Antibody | 1 | 1994 | 337 | 0.010 |
Why?
|
L-Lactate Dehydrogenase | 1 | 1994 | 411 | 0.010 |
Why?
|
Adrenal Cortex Hormones | 1 | 2002 | 1875 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2014 | 17872 | 0.010 |
Why?
|
Maltose | 1 | 1992 | 39 | 0.010 |
Why?
|
Kidney Cortex | 1 | 1992 | 169 | 0.010 |
Why?
|
Postoperative Period | 1 | 1997 | 1813 | 0.010 |
Why?
|
Child, Preschool | 4 | 1997 | 42251 | 0.010 |
Why?
|
Raffinose | 1 | 1992 | 53 | 0.010 |
Why?
|
Reference Values | 2 | 1990 | 4921 | 0.010 |
Why?
|
Hypertonic Solutions | 1 | 1992 | 82 | 0.010 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 2004 | 2751 | 0.010 |
Why?
|
CD4 Lymphocyte Count | 1 | 1998 | 2569 | 0.010 |
Why?
|
DNA Primers | 1 | 1996 | 2820 | 0.010 |
Why?
|
Lymphoid Tissue | 1 | 1993 | 445 | 0.010 |
Why?
|
Ultrasonics | 1 | 1992 | 207 | 0.010 |
Why?
|
Intestinal Absorption | 1 | 1992 | 400 | 0.010 |
Why?
|
Immunoglobulin M | 1 | 1996 | 1530 | 0.010 |
Why?
|
Solutions | 1 | 1992 | 412 | 0.010 |
Why?
|
Biopsy, Needle | 1 | 1996 | 1626 | 0.010 |
Why?
|
Cross Reactions | 1 | 1993 | 818 | 0.010 |
Why?
|
Antibody Specificity | 1 | 1993 | 1060 | 0.010 |
Why?
|
Secondary Prevention | 1 | 1997 | 1474 | 0.010 |
Why?
|
Lymphography | 1 | 1991 | 188 | 0.010 |
Why?
|
Mesentery | 1 | 1991 | 202 | 0.010 |
Why?
|
Allopurinol | 1 | 1992 | 198 | 0.010 |
Why?
|
Immunity, Cellular | 1 | 1996 | 1560 | 0.010 |
Why?
|
Rabbits | 1 | 1996 | 4779 | 0.010 |
Why?
|
Pancreatic Extracts | 1 | 1989 | 6 | 0.010 |
Why?
|
Vitamin B 12 | 1 | 1992 | 524 | 0.010 |
Why?
|
Glutathione | 1 | 1992 | 582 | 0.010 |
Why?
|
DNA, Viral | 1 | 1996 | 2201 | 0.010 |
Why?
|
Serum Albumin | 1 | 1992 | 675 | 0.010 |
Why?
|
Cytotoxicity, Immunologic | 1 | 1993 | 1351 | 0.010 |
Why?
|
Regional Blood Flow | 1 | 1992 | 1495 | 0.000 |
Why?
|
Gene Expression Regulation | 1 | 2007 | 11900 | 0.000 |
Why?
|
Anticoagulants | 1 | 2004 | 4813 | 0.000 |
Why?
|
Thromboxane A2 | 1 | 1988 | 88 | 0.000 |
Why?
|
Leukocytes | 1 | 1996 | 2029 | 0.000 |
Why?
|
Sugar Phosphates | 1 | 1987 | 44 | 0.000 |
Why?
|
Pan troglodytes | 1 | 1988 | 225 | 0.000 |
Why?
|
Microscopy, Electron, Scanning | 1 | 1989 | 944 | 0.000 |
Why?
|
Adenine Nucleotides | 1 | 1987 | 111 | 0.000 |
Why?
|
Guanosine Triphosphate | 1 | 1988 | 316 | 0.000 |
Why?
|
Plasma Exchange | 1 | 1988 | 158 | 0.000 |
Why?
|
Benzamidines | 1 | 1987 | 20 | 0.000 |
Why?
|
Phosphorylcholine | 1 | 1987 | 153 | 0.000 |
Why?
|
Adenosine | 1 | 1992 | 805 | 0.000 |
Why?
|
Cyclodextrins | 1 | 1987 | 66 | 0.000 |
Why?
|
Erythrocytes | 1 | 1996 | 2418 | 0.000 |
Why?
|
Regression Analysis | 1 | 1996 | 6341 | 0.000 |
Why?
|
Azathioprine | 1 | 1988 | 356 | 0.000 |
Why?
|
Urine | 1 | 1988 | 362 | 0.000 |
Why?
|
Bilirubin | 1 | 1988 | 437 | 0.000 |
Why?
|
Mothers | 1 | 1997 | 2192 | 0.000 |
Why?
|
Lymphocytes | 1 | 1994 | 2610 | 0.000 |
Why?
|
Esters | 1 | 1987 | 212 | 0.000 |
Why?
|
Fluorescent Antibody Technique | 1 | 1990 | 2468 | 0.000 |
Why?
|
Alanine Transaminase | 1 | 1988 | 605 | 0.000 |
Why?
|
Base Sequence | 1 | 1996 | 12449 | 0.000 |
Why?
|
Catheterization, Central Venous | 1 | 1989 | 527 | 0.000 |
Why?
|
Cold Temperature | 1 | 1988 | 786 | 0.000 |
Why?
|
Drug Interactions | 1 | 1989 | 1415 | 0.000 |
Why?
|
Microcirculation | 1 | 1989 | 1269 | 0.000 |
Why?
|
NAD | 1 | 1987 | 614 | 0.000 |
Why?
|
Molecular Sequence Data | 1 | 1996 | 17640 | 0.000 |
Why?
|
Atrophy | 1 | 1988 | 1632 | 0.000 |
Why?
|
Blood Proteins | 1 | 1988 | 1180 | 0.000 |
Why?
|
Adenosine Triphosphate | 1 | 1989 | 1989 | 0.000 |
Why?
|
Temperature | 1 | 1987 | 2229 | 0.000 |
Why?
|
Virus Replication | 1 | 1988 | 2435 | 0.000 |
Why?
|
Cholesterol | 1 | 1988 | 2902 | 0.000 |
Why?
|
Mitochondria | 1 | 1992 | 3624 | 0.000 |
Why?
|
Ischemia | 1 | 1987 | 1876 | 0.000 |
Why?
|
Weight Gain | 1 | 1989 | 2346 | 0.000 |
Why?
|
Body Weight | 1 | 1989 | 4614 | 0.000 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 1987 | 3768 | 0.000 |
Why?
|
Energy Metabolism | 1 | 1987 | 2879 | 0.000 |
Why?
|
Blood Platelets | 1 | 1987 | 2481 | 0.000 |
Why?
|
Infant | 1 | 1997 | 36202 | 0.000 |
Why?
|